National landscape assessment of academic medical center support for expanded access to investigational products

Expanded access (EA) provides a pathway for the clinical use of investigational products (drugs, biologics, and medical devices) for patients who are without satisfactory therapeutic options and for whom a clinical trial is not available. Academic medical centers (AMCs) are likely to encounter EA re...

Descripción completa

Detalles Bibliográficos
Autores principales: Gravelin, Misty, Adamo, Joan E., Ellison, Sharon, Segear, Erika, Parrish, Amanda B., Deeter, Christine, Hamill, Jennifer, Rigan, Laurie, Mashour, George A., Weatherwax, Kevin J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Special Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879891/
https://www.ncbi.nlm.nih.gov/pubmed/36755539
http://dx.doi.org/10.1017/cts.2022.494

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879891/
https://www.ncbi.nlm.nih.gov/pubmed/36755539
http://dx.doi.org/10.1017/cts.2022.494

Ejemplares similares